---
id: intestinal-parasites_099
category: organisms
tags: [giardia, cryptosporidium, cyclospora, entamoeba, intestinal-parasites]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Intestinal Parasites (Giardia, Cryptosporidium, Cyclospora, Entamoeba)

**Q:** What are the clinical features, diagnosis, and treatment of the major intestinal protozoan parasites (Giardia, Cryptosporidium, Cyclospora, Entamoeba histolytica)?

**A:**

## OVERVIEW

| **Parasite** | **Transmission** | **Key Clinical Feature** | **Diagnosis** | **Treatment** |
|--------------|------------------|--------------------------|---------------|---------------|
| ***Giardia lamblia*** | Fecal-oral, water | **Fatty diarrhea** (malabsorption) | Stool O&P, antigen | Metronidazole, tinidazole, nitazoxanide |
| ***Cryptosporidium*** | Fecal-oral, water | **Watery diarrhea** (self-limited in immunocompetent) | Acid-fast stain, PCR | Nitazoxanide (if immunocompetent), **ART (if HIV)** |
| ***Cyclospora cayetanensis*** | Fecal-oral, produce | **Prolonged diarrhea**, travelers | Acid-fast stain, PCR | **TMP-SMX** |
| ***Entamoeba histolytica*** | Fecal-oral, water | **Bloody diarrhea**, liver abscess | Stool O&P, serology, PCR | **Metronidazole + paromomycin** |

**Key Point:** **Giardia = fatty diarrhea**, **Crypto = watery diarrhea in HIV**, **Cyclospora = TMP-SMX**, **Entamoeba = bloody diarrhea + liver abscess**

---

## 1. GIARDIA LAMBLIA (GIARDIASIS)

**Organism:** *Giardia lamblia* (also *G. intestinalis*, *G. duodenalis*) - flagellated protozoan

**Transmission:**
- **Fecal-oral** (person-to-person)
- **Contaminated water** (most common in US)
- **Food-borne**
- **Zoonotic** (beavers, muskrats → "beaver fever")

**Epidemiology:**
- **Most common intestinal parasite** in US
- **Endemic:** Developing countries, daycare centers, wilderness areas

---

### **Clinical Features:**

**Incubation:** 1-2 weeks

**Symptoms:**
- **Watery diarrhea** → **Fatty, foul-smelling stools** (steatorrhea)
- **Flatulence, bloating, cramping**
- **Nausea, anorexia, weight loss**
- **Malabsorption** (if chronic - lactose intolerance, vitamin B12/fat-soluble vitamin deficiency)
- **NO fever** (typically afebrile)
- **NO blood/WBCs in stool**

**Duration:**
- **Acute:** 1-3 weeks
- **Chronic:** Months (10-20% if untreated)

**Key Point:** **Giardia = fatty, foul-smelling diarrhea** (steatorrhea, malabsorption)

---

### **Diagnosis:**

| **Test** | **Specimen** | **Sensitivity** | **Notes** |
|----------|--------------|-----------------|-----------|
| **Stool ova & parasites (O&P)** | Stool | **50-70% (single sample)** | ↑ Sensitivity with 3 specimens (90%) |
| **Stool antigen test (EIA/DFA)** | Stool | **90-95%** | **Preferred** (single specimen) |
| **PCR** | Stool | **>95%** | High sensitivity/specificity |
| **String test (Entero-Test)** | Duodenal fluid | **~70%** | Rarely used (swallow capsule with string) |

**Key Point:** **Stool antigen test = preferred** (high sensitivity, single specimen)

---

### **Treatment:**

**First-Line Options:**

| **Agent** | **Dosing** | **Duration** | **Efficacy** |
|-----------|------------|--------------|--------------|
| **Tinidazole** (preferred) | **2 g PO x 1 dose** (adults)<br>**50 mg/kg x 1 dose** (children, max 2 g) | **Single dose** | **90-95%** |
| **Metronidazole** | **250 mg PO TID** (adults)<br>**15 mg/kg/day divided TID** (children) | **5-7 days** | **80-90%** |
| **Nitazoxanide** (FDA-approved) | **500 mg PO BID** (adults)<br>Age-based dosing (children >1 year) | **3 days** | **80-90%** |

**Alternative (Pregnancy):**
- **Paromomycin** 25-35 mg/kg/day PO divided TID x 7 days (poorly absorbed, safe in pregnancy)

**Refractory Giardiasis (Treatment Failure):**
- **Combination therapy:** Metronidazole + albendazole OR tinidazole + albendazole
- **Prolonged course:** Nitazoxanide 500 mg BID x 7-14 days

**Key Point:** **Tinidazole = single dose** (preferred for compliance), **metronidazole = 5-7 days**

---

### **Prevention:**

- **Water purification** (boil or filter <1 micron)
- **Hand hygiene** (soap and water - alcohol sanitizers less effective against cysts)

---

## 2. CRYPTOSPORIDIUM (CRYPTOSPORIDIOSIS)

**Organism:** *Cryptosporidium parvum*, *C. hominis* (intracellular apicomplexan protozoan)

**Transmission:**
- **Fecal-oral** (person-to-person)
- **Contaminated water** (chlorine-resistant oocysts)
- **Animal contact** (calves, lambs)
- **Recreational water** (swimming pools, water parks)

**Epidemiology:**
- **Leading cause of waterborne diarrhea** in US
- **Outbreaks:** Daycare centers, swimming pools

---

### **Clinical Features:**

**Immunocompetent:**
- **Watery diarrhea** (profuse, non-bloody)
- **Cramping, nausea, vomiting**
- **Low-grade fever**
- **Self-limited** (1-2 weeks)

**Immunocompromised (HIV, CD4 <100):**
- **Severe, chronic watery diarrhea** (cholera-like, >10 L/day)
- **Wasting, dehydration**
- **Biliary tract involvement** (cholangitis, cholecystitis - AIDS cholangiopathy)
- **Respiratory involvement** (rare - cough, dyspnea)

**Key Point:** **Cryptosporidium in HIV = chronic, profuse watery diarrhea** (cholera-like)

---

### **Diagnosis:**

| **Test** | **Specimen** | **Sensitivity** | **Notes** |
|----------|--------------|-----------------|-----------|
| **Modified acid-fast stain** | Stool | **60-80%** | **Red/pink oocysts** (4-6 μm) |
| **Stool antigen test (EIA/DFA)** | Stool | **80-95%** | Preferred |
| **PCR** | Stool | **>95%** | High sensitivity |

**Key Point:** **Acid-fast stain = red/pink oocysts** (Cryptosporidium)

---

### **Treatment:**

**Immunocompetent:**
- **Supportive care** (hydration) - **self-limited**
- **Nitazoxanide** 500 mg PO BID x 3 days (FDA-approved, may shorten duration)

**Immunocompromised (HIV):**

| **Approach** | **Details** |
|--------------|-------------|
| **Antiretroviral therapy (ART)** | **MOST IMPORTANT** - Immune reconstitution (CD4 >200) = resolution |
| **Nitazoxanide** | **500-1000 mg PO BID x 14 days** (adjunctive)<br>**Efficacy:** 71-90% if CD4 >50, **limited if CD4 <50** |
| **Paromomycin** | 500 mg PO QID (alternative, limited efficacy) |

**Key Point:** **ART = cornerstone of treatment** for HIV-associated cryptosporidiosis (immune reconstitution)

---

### **Prevention:**

- **Chlorine-resistant** → Boil water or use <1 micron filter
- **Avoid swimming** if diarrhea (for 2 weeks after resolution)

---

## 3. CYCLOSPORA CAYETANENSIS (CYCLOSPORIASIS)

**Organism:** *Cyclospora cayetanensis* (apicomplexan protozoan)

**Transmission:**
- **Fecal-oral** (contaminated produce - raspberries, basil, cilantro, lettuce)
- **NOT person-to-person** (oocysts require days-weeks to sporulate)

**Epidemiology:**
- **Travel-associated** (Latin America, South/Southeast Asia, Africa)
- **Outbreaks:** Imported produce

---

### **Clinical Features:**

**Incubation:** 1 week (average)

**Symptoms:**
- **Watery diarrhea** (explosive, non-bloody)
- **Prolonged/relapsing course** (weeks to months if untreated)
- **Anorexia, weight loss**
- **Fatigue, myalgias**
- **Flu-like symptoms** (low-grade fever)

**Key Point:** **Cyclospora = prolonged, relapsing diarrhea** in travelers

---

### **Diagnosis:**

| **Test** | **Specimen** | **Sensitivity** | **Notes** |
|----------|--------------|-----------------|-----------|
| **Modified acid-fast stain** | Stool | **~50%** | **Variably acid-fast** (larger oocysts 8-10 μm than Cryptosporidium) |
| **Autofluorescence (UV)** | Stool | **High** | **Blue autofluorescence** under UV microscopy |
| **PCR** | Stool | **>95%** | Preferred |

**Key Point:** **Cyclospora = blue autofluorescence** under UV (vs Cryptosporidium = red/pink acid-fast)

---

### **Treatment:**

**First-Line:**

| **Agent** | **Dosing** | **Duration** |
|-----------|------------|--------------|
| **Trimethoprim-sulfamethoxazole (TMP-SMX)** | **160/800 mg (1 DS tablet) PO BID** | **7-10 days** |

**HIV Patients:**
- **Treatment:** TMP-SMX 1 DS tablet PO QID x 10 days → BID x 3 weeks
- **Chronic suppression:** TMP-SMX 1 SS tablet PO daily (if CD4 <200 or recurrent)

**Alternative (If Sulfa Allergy):**
- **Ciprofloxacin** 500 mg PO BID x 7 days (less effective)
- **Nitazoxanide** (limited data)

**Key Point:** **TMP-SMX = treatment of choice** for Cyclospora

---

### **Prevention:**

- **Wash produce** (may not eliminate oocysts)
- **Avoid raw produce** in endemic areas

---

## 4. ENTAMOEBA HISTOLYTICA (AMEBIASIS)

**Organism:** *Entamoeba histolytica* (protozoan)

**Transmission:**
- **Fecal-oral** (contaminated water/food)
- **Person-to-person** (men who have sex with men)

**Epidemiology:**
- **Endemic:** Developing countries (India, Africa, Mexico, Central/South America)
- **~50 million infections/year** worldwide

**Key Point:** Distinguish from non-pathogenic ***E. dispar*** (90% of "E. histolytica" infections are E. dispar)

---

### **Clinical Syndromes:**

---

#### **A. Intestinal Amebiasis (Amebic Colitis):**

**Clinical Features:**
- **Gradual onset** (days to weeks)
- **Bloody diarrhea** ("dysentery") - blood/mucus in stool
- **Cramping, tenesmus**
- **Low-grade fever** (or afebrile)
- **Weight loss**

**Severe Complications:**
- **Toxic megacolon**
- **Colonic perforation**
- **Ameboma** (inflammatory mass mimicking colon cancer)

**Key Point:** **Amebic colitis = bloody diarrhea** (dysentery)

---

#### **B. Amebic Liver Abscess (ALA) - Most Common Extraintestinal Manifestation:**

**Clinical Features:**
- **Fever** (high, intermittent)
- **Right upper quadrant pain** (tender liver)
- **NO jaundice** (typically)
- **Weight loss, night sweats**
- **Elevated alkaline phosphatase**

**Imaging (CT/Ultrasound):**
- **Single abscess** (70-80%) - **right lobe** (most common)
- **Round, well-defined, hypodense lesion**
- **"Anchovy paste" aspirate** (necrotic debris - if aspirated)

**Key Point:** **Amebic liver abscess = single right lobe abscess** + fever + RUQ pain

---

### **Diagnosis:**

| **Test** | **Use** | **Sensitivity** | **Notes** |
|----------|---------|-----------------|-----------|
| **Stool O&P (microscopy)** | Intestinal amebiasis | **25-60% (single sample)** | Cannot distinguish *E. histolytica* from *E. dispar* |
| **Stool antigen (EIA)** | Intestinal amebiasis | **>90%** | Detects *E. histolytica* (NOT *E. dispar*) |
| **PCR** | Intestinal amebiasis | **>95%** | Distinguishes species |
| **Serology (IgG)** | **Liver abscess** | **>95%** | **Preferred for liver abscess**<br>Remains positive for years |
| **Aspirate culture** | Liver abscess | Low yield | "Anchovy paste" appearance |

**Key Point:** **Serology (IgG) >95% sensitive** for amebic liver abscess

---

### **Treatment:**

**Two-Step Approach:**
1. **Tissue amebicide** (kill trophozoites in tissue)
2. **Luminal amebicide** (eradicate cysts in intestinal lumen - prevent recurrence/transmission)

---

#### **Intestinal Amebiasis:**

**Step 1: Tissue Amebicide:**

| **Agent** | **Dosing** | **Duration** |
|-----------|------------|--------------|
| **Metronidazole** (preferred) | **750 mg PO TID** | **7-10 days** |
| **OR Tinidazole** | **2 g PO daily** | **3 days** |

**Step 2: Luminal Amebicide (ESSENTIAL):**

| **Agent** | **Dosing** | **Duration** |
|-----------|------------|--------------|
| **Paromomycin** (preferred) | **25-35 mg/kg/day PO divided TID** (max 3 g/day) | **7 days** |
| **OR Iodoquinol** | **650 mg PO TID** | **20 days** |

**Key Point:** **Metronidazole + paromomycin** = complete treatment (tissue + luminal)

---

#### **Amebic Liver Abscess:**

**Treatment:**

| **Agent** | **Dosing** | **Duration** |
|-----------|------------|--------------|
| **Metronidazole** | **750 mg PO TID** | **7-10 days** |
| **PLUS Paromomycin** (luminal) | **25-35 mg/kg/day PO divided TID** | **7 days** |

**Aspiration:**
- **NOT routinely needed** (medical treatment alone usually sufficient)
- **Indications for aspiration:**
  - Large abscess (>5 cm)
  - Left lobe abscess (risk of rupture into pericardium)
  - No response to medical therapy (48-72 hours)
  - Superinfection suspected

**Key Point:** **Medical treatment alone** usually sufficient (aspiration rarely needed)

---

#### **Asymptomatic Cyst Passers:**

**Treatment (Luminal Amebicide ONLY):**
- **Paromomycin** 25-35 mg/kg/day PO divided TID x 7 days
- **Prevent transmission** + prevent invasive disease (4-10% develop symptoms within 1 year if untreated)

---

### **Prognosis:**

**Intestinal Amebiasis:**
- **Good with treatment** (>95% cure)

**Amebic Liver Abscess:**
- **Good with treatment** (>90% cure)
- **Rupture (rare):** Into peritoneum, pleura, pericardium (high mortality)

---

## COMPARISON TABLE

| **Feature** | **Giardia** | **Cryptosporidium** | **Cyclospora** | **Entamoeba histolytica** |
|-------------|-------------|---------------------|----------------|----------------------------|
| **Stool appearance** | Fatty, foul-smelling | Watery (profuse in HIV) | Watery | Bloody (dysentery) |
| **Fever** | NO | Low-grade | Low-grade | Variable |
| **Duration (untreated)** | 1-3 weeks (can be chronic) | 1-2 weeks (immunocompetent)<br>Chronic (HIV) | Weeks to months | Variable |
| **Diagnosis** | Stool antigen (preferred) | Acid-fast stain, antigen | Acid-fast, **UV blue autofluorescence** | **Serology** (liver abscess) |
| **Treatment** | Tinidazole (single dose) OR metronidazole | **ART** (HIV), nitazoxanide | **TMP-SMX** | **Metronidazole + paromomycin** |
| **Key complication** | Malabsorption | Chronic diarrhea (HIV) | Prolonged/relapsing | **Liver abscess** |

---

**Mnemonic: "Giardia = Greasy (Fatty Diarrhea)"**
- **G**iardia
- **G**reasy, foul-smelling stools (steatorrhea)
- Malabsorption

**Mnemonic: "Crypto in HIV = Cholera-like (Profuse Watery)"**
- **C**ryptosporidium
- **C**holera-like diarrhea (profuse watery in HIV)
- **ART = cornerstone**

**Mnemonic: "Cyclospora = TMP-SMX"**
- **C**yclospora
- **S**MX = **S**ulfamethoxazole + trimethoprim
- Blue autofluorescence under UV

**Mnemonic: "Entamoeba = 2-Step (Metronidazole + Paromomycin)"**
- **E**ntamoeba
- **M**etronidazole (tissue) + **P**aromomycin (luminal)
- Liver abscess (single, right lobe)

**Clinical Pearls:**
- **Giardia = #1 intestinal parasite in US** (fatty, foul-smelling diarrhea)
- **Tinidazole = single dose** for giardiasis (preferred for compliance)
- **Cryptosporidium = chlorine-resistant** (waterborne outbreaks)
- **ART = cornerstone** for HIV-associated cryptosporidiosis (immune reconstitution)
- **Nitazoxanide effective if CD4 >50** (limited efficacy if CD4 <50)
- **Cyclospora = prolonged/relapsing diarrhea** in travelers
- **TMP-SMX = treatment of choice** for Cyclospora
- **Cyclospora = blue autofluorescence** under UV (vs Cryptosporidium = red/pink acid-fast)
- **Entamoeba histolytica = bloody diarrhea** (dysentery) + **liver abscess**
- **Serology >95% sensitive** for amebic liver abscess
- **Metronidazole + paromomycin** = complete treatment (tissue + luminal eradication)
- **Paromomycin = luminal amebicide** (poorly absorbed, safe in pregnancy)
- **Amebic liver abscess:** Single, right lobe (70-80%), "anchovy paste"
- **Aspiration rarely needed** for liver abscess (medical treatment usually sufficient)
- **Asymptomatic cyst passers:** Treat with luminal amebicide (prevent transmission + invasive disease)

**Media:** None

**Sources:** [CDC 2024 - Giardia clinical care], [IDSA guidelines - Giardiasis treatment], [NIH/HIVMA 2024 - Cryptosporidiosis in HIV], [CDC 2024 - Cryptosporidium clinical care], [CDC Yellow Book 2024 - Cyclosporiasis], [CDC Yellow Book 2024 - Amebiasis], [NEJM 2024 - Intestinal protozoa], [Clinical Infectious Diseases 2024 - Amebiasis treatment]
